Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Spero Therapeutics Inc (NASDAQ:SPRO)

12.06
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
9.84
Today|||52-Week Range
15.40
+2.64%
Year-to-Date
No recent news for Spero Therapeutics Inc.

Today’s Trading

Previous close12.06
Today’s open11.58
Day’s range11.58 - 12.30
Volume36,186
Average volume (3 months)113,624
Market cap$166.5M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-122.89%
Earnings growth (this year)--
Earnings growth (next 5 years)+0.58%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$335.0K
Annual profit (last year)-$25.5M
Net profit margin-7,609.25%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Ankit A. Mahadevia
Chief Operating Officer
Cristina Larkin
Corporate headquarters
Cambridge, Massachusetts

Forecasts